Abstract
Human uterine spiral artery remodeling (SAR) is a tightly regulated process involving complex interactions between interstitial and endovascular extravillous trophoblasts (iEVTs and enEVTs) and diverse maternal decidual cell populations. However, the intrinsic spatiotemporal dynamics of SAR in human placentation remain poorly understood, largely due to the limited availability of high-quality maternal-fetal interface specimens. Electively terminated early pregnancies offer a valuable resource for studying SAR in situ, yet inconsistent methods for distinguishing fragmented villous and decidual tissues have hindered reproducibility and interpretation. Herein we present a standardized protocol for the classification and characterization of high-quality maternal-fetal interface specimens from elective terminations by integrating stereomicroscopic evaluation with confirmation by immunohistochemistry and immunofluorescence microscopy. Combined with multiplex immunofluorescence imaging with cell-type-specific markers, this approach enabled precise spatial mapping and quantification of key morphological and cellular events in SAR from gestational weeks 5–10. Our analyses reveal that SAR initiates as early as week 5 with extraluminal recruitment of natural killer (NK) cells, followed by the formation of tightly packed EVT plugs within the lumens of spiral arteries in the decidua compacta; these plugs progressively extend deeper into the vessels and gradually loosen as gestation progresses. Notably, enEVTs appear to acquire NK cell-like phenotypes that may facilitate the displacement of endothelial and smooth muscle cells, promoting progressive vessel dilation. In summary, we provide a robust and reproducible method for assessing physiological SAR in early human pregnancy, promoting the adoption of our methodology in future studies of pathological SAR and related pregnancy disorders.
Keywords: standardized protocol, electively aborted materials, maternal-fetal interface
A standardized protocol for classifying maternal-fetal interface specimens from electively aborted materials at gestational weeks 5–10 was developed to quantify the spatiotemporal spiral artery remodeling dynamics in early human pregnancy.
Graphical Abstract
Graphical Abstract.

Introduction
Human placentation begins approximately 5–7 days post-fertilization, when trophectoderm-derived extraembryonic cells first establish contact with the uterine endometrial lining. This process is initiated at the implantation site by the formation of the primitive syncytium, a multinucleated layer that encases the underlying mononuclear cytotrophoblast (CTB) cells. The primitive syncytium secretes proteolytic enzymes that degrade and loosen the surrounding decidual tissue, enabling its expansion into the resulting interstitial spaces [1]. By approximately 2 weeks post-fertilization (corresponding to ~week 4 of gestation, counting from the last menstrual period), CTBs begin to migrate into these spaces and, together with mesenchymal cells, form the primitive placental villi. Continued proliferation and differentiation of CTBs give rise to the foundational villous architecture of the placenta, which consists of a mesenchymal core containing fetal blood vessels, an inner layer of villous CTBs, and an outer covering of syncytiotrophoblast (STB) [2]. Around gestational week 5, a subset of CTBs breaches the STB layer and differentiates into invasive extravillous trophoblasts (EVTs) [3–6]. These EVTs infiltrate the decidualized uterine stroma and extend into the superficial myometrium, facilitating physical anchorage of the developing placenta to the uterine wall.
The paired uterine arteries arise from the internal iliac arteries and give rise to a hierarchical vascular network comprising arcuate, radial, basal, and spiral arteries (SAs). Within the myometrium, the uterine artery branches into arcuate arteries, which course circumferentially and further subdivide into radial arteries. As the radial arteries approach the endometrial–myometrial junction, they give rise to basal arteries and SAs, the latter of which penetrate the endometrium. Spiral arteries are distinguished by their coiled morphology and serve as the primary blood supply to the functional layer of the endometrium [7]. During pregnancy, EVTs invade and form cell aggregates referred to as EVT plugs in the lumens of SAs. This invasion is accompanied by endothelial cell (EC) apoptosis, dedifferentiation of vascular smooth muscle cells (VSMCs), degradation of the extracellular matrix with fibrinoid deposition, and EVT incorporation into the vessel wall as endovascular EVTs (enEVTs) [8]. Collectively, these changes define the process of SA remodeling (SAR), which transforms the small-caliber, high-resistance SAs into dilated, low-resistance vessels with widened funnel-shaped openings into the intervillous space. This transformation enables the establishment of low-velocity maternal blood flow to minimize shear stress and to optimize placental perfusion that carries out the bi-directional maternal-fetal exchanges [9]. Spiral artery remodeling occurs in coordination with decidualization and trophoblast differentiation/invasion processes, involving complex interactions between various fetal trophoblasts and maternal decidual, myometrial, immune, and vascular ECs and VSMCs. These events culminate in the formation of the maternal–fetal interface, which is believed to structurally complete by gestational weeks 10–12 [10, 11]. Importantly, SAR is a critical event in placental development that underpins a successful pregnancy. Deficient or aberrant SAR is strongly associated with a spectrum of pregnancy complications, including early pregnancy loss, miscarriage, placental abruption, preeclampsia, and fetal growth restriction [12].
Despite extensive investigations, key questions remain regarding the intrinsic spatiotemporal dynamics of SAR. Ongoing debates concern the timing of SAR initiation [3, 13] and whether SAR occurs primarily intraluminally via enEVTs or extraluminally via interstitial EVTs (iEVTs) or other maternal cell types [11, 14, 15]. The mechanisms controlling the formation and resolution of EVT plugs also remain poorly understood, despite consistent evidence of their presence during varying gestation ages [16–19]. Using fresh maternal-fetal interface specimens, we recently observed EVT plugs within SAs that retained intact or partially disrupted vessel walls during early gestation [20, 21]. Complementing these findings, a digital quantification study of serial sections from the historical Boyd and Dixon placental collections demonstrated that EVT plugs persist within SA lumens throughout the first and second trimesters. These plugs become increasingly compact with advancing gestation, while their intercellular channel sizes expand [22]. These observations underscore persistent gaps in the understanding of EVT plug dynamics and associated cellular compositions. A more refined characterization of the spatiotemporal behavior of EVTs and associated maternal cells is needed to fully elucidate physiological SAR during early pregnancy.
A common denominator across many studies of SAR is the reliance on specimens sourced either from archived collections such as the Boyd collection or from fresh tissues obtained through elective abortions. However, variable protocols for sample collection, preservation, and processing may contribute to inconsistencies in SAR-related findings across different studies. More recently, archived hysterectomy-derived samples have been utilized to access intact maternal-fetal interface tissues for spatial transcriptomic analysis of SAR [23]. While valuable and cutting edge, such samples are extremely limited in availability, and consistent sampling across gestational stages remains a major challenge, resulting in spatial and temporal gaps in the understanding of SAR.
Elective abortions performed between gestational weeks 5–10 are legally permitted in certain countries, including China under strict regulations. This provides a unique opportunity to collect fresh villous and decidual tissues during a critical window of early placental development. However, these tissues are often fragmented by mechanical forces during surgical extraction, making it difficult to discern the native spatial architecture of the villous and decidual compartments. To overcome this challenge, we developed a standardized protocol for classifying maternal-fetal interface specimens obtained from the surgically removed materials during gestation weeks 5–10. By integrating multiplex immunofluorescence imaging with antibodies targeting specific cell markers at the maternal-fetal interface, our approach enables accurate delineation of spatial relationships among fetal trophoblasts and maternal decidual cells and vascular ECs and SMCs during weeks 5–10 of gestation. This methodology not only facilitates the reconstruction of the maternal-fetal interface but also provides novel insights into the spatiotemporal dynamics of SAR during early human placentation.
Materials and methods
Ethics, human subjects, and sample collection
This study was approved by the Ethics Committees of the Institute of Zoology, Chinese Academy of Sciences (IOZ-2022-043), and the Peking University Third Hospital (2022 No. 379-02). Pregnant women who conceived naturally and opted for elective surgical abortion were recruited from the Family Planning Clinic at the Peking University Third Hospital (Beijing, China). Exclusion criteria included conception via assisted reproductive technologies, fetal chromosomal or congenital abnormalities, a history of renal or cardiovascular disease, and any gestational complications such as recurrent spontaneous miscarriage, gestational diabetes, hypertensive disorders of pregnancy, or intrauterine fetal death. Written informed consent was obtained for all tissue donations. Samples were collected from 15 surgical procedures. Gestational age was determined by ultrasound measurement of embryo diameter immediately prior to surgery. Post-surgical materials, including villous and decidual tissues, were collected immediately, placed in ice-cold phosphate-buffered saline (PBS), transported to the research laboratory, and processed within 1 h. The clinical characteristics of the study participants are summarized in Table 1.
Table 1.
Clinical data of participants.
| Case No. | Gestational age (Week+day) | Maternal age (Year) | Parity (Time) | Gravida (Time) | BMI* (Kg/m2) | Blood pressure (mm Hg. S/D)* |
|---|---|---|---|---|---|---|
| 1 | 5+1 | 31 | 1 | 1 | 24.84 | 115/69 |
| 2 | 6 | 38 | 0 | 1 | 22.03 | 103/55 |
| 3 | 6+3 | 38 | 2 | 2 | 20.66 | 107/69 |
| 4 | 6+5 | 39 | 2 | 2 | 22.04 | 115/61 |
| 5 | 6+5 | 33 | 2 | 2 | 23.51 | 110/64 |
| 6 | 7+1 | 38 | 2 | 3 | 25.21 | 114/64 |
| 7 | 7+5 | 27 | 0 | 0 | 18.37 | 97/62 |
| 8 | 7+6 | 25 | 1 | 2 | 18.17 | 103/65 |
| 9 | 8 | 35 | 0 | 2 | 18.03 | 126/68 |
| 10 | 8+2 | 30 | 0 | 0 | 18.78 | 125/65 |
| 11 | 9+2 | 38 | 0 | 0 | 20.25 | 107/66 |
| 12 | 9+2 | 38 | 2 | 2 | 20.31 | 102/61 |
| 13 | 9+4 | 21 | 0 | 0 | 19.63 | 106/67 |
| 14 | 9+6 | 31 | 1 | 2 | 20.20 | 111/64 |
| 15 | 10+1 | 33 | 0 | 0 | 17.92 | 115/63 |
BMl: Body mass index; S/D: Systolic/Diastolic blood pressure.
Stereomicroscopic separation of decidua and placenta villi
Aborted tissues were rinsed with ice-cold PBS to remove blood clots and then immersed in fresh PBS. Under a 50× stereomicroscope, placental villi were identified based on the morphological characteristics of the chorionic sac. Villi appeared as white, floating tissues with a densely branched structure. Remaining tissues were separated and identified as decidua, comprising various decidual subtypes (Figure 1A). Decidual tissues were further classified into three types based on macroscopic features, including thickness, stiffness, surface smoothness, and the presence or absence of residual villous tissues. These classifications were subsequently validated by immunohistochemical analysis.
Figure 1.
Classification of human early pregnancy abortion tissues. (A) Schematic diagram showing the chorionic sac and the three types of decidual tissues: decidua basalis, capsularis, and parietalis. (B) Representative gross morphology of villous tissues at 6 weeks (right) and 9 weeks (left) of gestation, imaged under a stereomicroscope at 50× magnification. (C) Gross morphology of aborted tissues at 8 weeks of gestation, classified into chorionic sac, decidua parietalis, decidua basalis, and decidua capsularis. (D) Gross morphology (top) of decidua capsularis at the uterine luminal side [U] and villous side [V]; corresponding immunohistochemical staining for CK7 (bottom) to visualize trophoblasts. (E) Gross morphology (top) of decidua parietalis at the uterine luminal side [U] and the myometrial detachment surface [M]; CK7 immunostaining (bottom) highlights the absence of trophoblasts. (F) Gross morphology (top) of decidua basalis at the villous side [V] and muscle layer detachment surface [M]; CK7 immunostaining (bottom) shows abundant trophoblast infiltration. G, gland; iEVT, interstitial extravillous trophoblast; enEVT, endovascular extravillous trophoblast; SA, spiral artery; V, vein; AV, anchoring villi; CCC, cytotrophoblastic cell column. Scale bars: Black = 50 μm; Yellow = 2 mm.
Paraffin-embedded section preparation
The separated villous and decidual tissues were immediately fixed in 4% formaldehyde at 4°C for 12 h. After fixation, samples were rinsed with PBS, dehydrated through a graded ethanol series, and cleared in xylene. For basal decidual tissues, special care was taken during paraffin embedding to orient the specimens such that serial sections extended from the superficial implantation layer (decidua compacta) to the deeper layer (decidua spongiosa). Paraffin blocks were sectioned at 5 μm thickness; the sections were stored at room temperature (RT) until further analysis.
Immunohistochemistry
Paraffin sections were dewaxed in xylene and rehydrated through a graded ethanol series. Endogenous peroxidase activity was quenched using hydrogen peroxide. Antigen retrieval was achieved by heating the sections in trisodium citrate dihydrate buffer. Following antigen retrieval, nonspecific binding was blocked with 3% fetal bovine serum albumin in PBS. Sections were then incubated overnight at 4°C with a primary antibody against human cytokeratin 7 (CK7, 1:8000; Abcam #ab181598). After three washes (5 min each) in PBS, sections were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (PV-6001; ZSGB-BIO, China) for 1 h at RT. Immunoreactivity was visualized using diaminobenzidine (ZLI-9019, ZSGB-BIO, China) as the chromogen, followed by hematoxylin counterstaining. Digital images were acquired using a light microscope equipped with a 10× ocular lens and 2×, 10×, and 20× air objectives, and captured with an Olympus DP72 CCD camera (Olympus, Japan).
Multiplexed immunofluorescence imaging of spiral artery remodeling
Multiplexed immunofluorescence microscopy for imaging analysis of SAR was performed using the Opal multiple-color manual IHC kit (Akoya Biosciences, Marlborough, MA, USA), which includes Opal 520, 570, 620, 650, and 690 fluorophores. Each fluorophore was used to label HRP-conjugated secondary antibodies (Vector Laboratories, Burlingame, CA, USA), enabling the sequential detection of five distinct primary antibodies targeting different cellular markers within the same tissue section. Briefly, sections of maternal–fetal interface tissue were dewaxed in xylene and rehydrated through a graded ethanol series. After blocking endogenous peroxidase activity and antigen retrieval, sections were blocked with Opal blocking buffer at RT for 10 min, then incubated with a primary antibody diluted in Opal antibody diluent at 37°C for 1 h. After washing three times for 5 min each with Tris-buffered saline containing Tween-20 (TBST), sections were incubated with an HRP-conjugated secondary antibody at RT for 10 min. After another series of TBST washes, the appropriate Opal fluorophore was applied according to the manufacturer’s instructions at 37°C for 6 min. This staining cycle was repeated sequentially for each of the five primary antibodies. Upon completion of all staining steps, sections were washed thoroughly and mounted using a DAPI-containing antifade mounting medium (ZSGB-BIO, ZLI-9557) for nuclear counterstaining. Imaging was performed using a Leica Stellaris 5 confocal microscope (Leica Microsystems, Germany) equipped with a 10× ocular lens and 20× air or 40× oil immersion objectives. Whole-section images were acquired for analysis of dynamic cellular and structural changes, including the presence of EVT plugs in SAs, using the LAS-X FLIM/FCS module (Leica Microsystems). The analysis included at least ten sections per sample, with sections taken from every 20th slice across a total of more than 200 slices continuously collected. Each fluorophore corresponded to a specific target protein, detected using white laser excitation at the following wavelengths (nm): 494 (Opal 520), 550 (Opal 570), 588 (Opal 620), 627 (Opal 650), 676 (Opal 690), and 368 (DAPI). Corresponding emission detection ranges were set to 497–544, 564–606, 617–630, 633–653, 682–762, and 420–467 nm, respectively.
The following primary antibodies were used for multiplex immunofluorescence staining: anti-cytokeratin 7 (CK7, 1:8000; Abcam, #ab181598), anti-human leukocyte antigen-G (HLA-G, 1:200; Abcam, #ab52455), anti-E-cadherin (E-cad, 1:200; Cell Signaling Technology, #3195S), anti-neural cell adhesion molecule 1 (NCAM1, 1:200; Abcam, #ab75813), anti-von Willebrand factor (vWF, 1:200; Abcam, #ab6994), and anti-α-smooth muscle actin (αSMA, 1:400; Abcam, #ab5694). CK7 was used as a general trophoblast marker [24], while HLA-G served as a specific marker for EVTs [25]. E-cadherin, an epithelial cell marker, is frequently expressed during EVT differentiation [8]. NCAM1 was used to label decidual natural killer (dNK) cells [26]. Interstitial EVTs were identified as HLA-G+/NCAM1− cells, whereas enEVTs were defined as HLA-G+/NCAM1+ cells [27, 28]. vWF was used to identify ECs [29], and αSMA was used to mark VSMCs [30].
Spatiotemporal analysis of spiral artery remodeling
Basal decidua samples containing the maternal–fetal interface were collected from 15 elective abortion surgeries (Table 1), paraffin-embedded, and sectioned for spatiotemporal analysis of SAR across different gestational ages and decidual zones (compacta vs. spongiosa). From each sample, approximately 200 consecutive sections (5 μm) were cut. For analysis, every 20th section was selected, resulting in at least 10 sections per sample. Multiplex immunofluorescence microscopy was performed on these sections using antibodies against HLA-G, NCAM1, vWF, and αSMA to label EVTs, dNK cells, ECs, and VSMCs, respectively. SAR was classified into three distinct stages based on cellular distribution and vascular structure, as previously described [31]:
Un-remodeled SAs—characterized by multiple layers of VSMCs and intact endothelium without EVT infiltration.
Actively remodeling SAs—identified by EVT invasion beyond the vessel wall, partial disruption of the VSMC layer, and initiation of EC replacement.
Fully remodeled SAs—marked by complete replacement of both ECs and VSMCs by EVTs.
Statistical analysis
Data were expressed as the mean ± standard deviation (SD). Values were calculated either as percentages or as fold changes relative to gestational week 5. Statistical analyses were performed using GraphPad Prism version 9.0 (GraphPad Software, San Diego, CA, USA). Differences between two groups were assessed using Student t-test, while comparisons among multiple groups were conducted using one-way analysis of variance, followed by Bonferroni post hoc tests when appropriate. A P-value of less than 0.05 was considered statistically significant.
Results
Tissue composition and characteristics of decidual subtypes
Elective abortion surgeries resulted in the complete removal of both decidual and fetal tissues [22], as confirmed in Figure 1A. The recovered tissues included fetal components such as the chorionic sac and placental villi and maternal uterine decidua. The decidua comprises three morphologically distinct regions: 1) basal decidua located between the chorionic sac (V) and the uterine myometrium (M); 2) capsular decidua surrounding the chorionic sac (V) and facing the uterine cavity (U); and 3) parietal decidua positioned opposite the basal decidua, lining the remainder of the uterine cavity. Morphologically, fetal-derived placental villi displayed a densely branched, tree-like structure, with increasing complexity observed at later gestational stages (Figure 1B). The collected specimens typically included 20–40 tissue fragments, which were grossly classified into basal, capsular, or parietal decidua based on surface characteristics and structural features (Figure 1C).
Approximately 20% of the decidual fragments were thin and stiff, with thicknesses ranging from 0.05 to 0.1 mm (Figure 1C). Stereomicroscopic examination revealed a smooth surface on one side and a rough surface on the other, with occasional attachment of villous branches (Figure 1D, top). These features are characteristic of capsular decidua, which lies on the surface of the chorionic sac. As gestation progressed from weeks 5 to 10, capsular decidua specimens became progressively thinner, consistent with the expansion of the chorionic sac. Immunohistochemical staining for CK7 confirmed the presence of dispersed villi and EVTs, accompanied by sparse vasculature (Figure 1D, bottom), hallmark histological features of capsular decidua.
Approximately 70% of the decidual specimens were soft tissues, measuring 1.0 to 3.0 mm in thickness (Figure 1C). One side of these specimens exhibited a smooth, glandular epithelial surface, with underlying blood vessels clearly visible. Stereoscopic examination revealed a smooth surface with gland-like openings on one side, and a relatively rough opposite surface marked by clear evidence of connective tissue tearing likely resulting from surgical separation (Figure 1E, top). Immunohistochemical staining for CK7 confirmed the presence of abundant glands and some intact blood vessels, but notably, a lack of EVTs within the stroma (Figure 1E, bottom). These features are consistent with the parietal decidua.
Less than 10% of the decidual specimens appeared as solid tissues, with a thickness ranging from approximately 0.5 to 1.5 mm (Figure 1C). Stereoscopic observation showed that both surfaces were rough. One side displayed numerous characteristic groove-like depressions, loose gland-like openings, and a relatively high density of residual villi; the opposite surface exhibited tearing features similar to those seen in parietal decidua (Figure 1F, top). CK7 immunostaining revealed hallmark features of the basal decidua containing the maternal–fetal interface, including anchoring villi with cytotrophoblastic cell columns (CCCs) embedded in the decidual stroma, abundant iEVTs, EVT plugs, enEVTs within uterine blood vessels, and expanded glands lined by a thin epithelial layer (Figure 1F, bottom).
Identification of maternal-fetal interface in basal decidua
The maternal-fetal interface forms at the site of blastocyst implantation. Surgical abortion disrupts the structural integrity between placental villi and the decidua, highlighting the need to carefully identify and isolate intact maternal-fetal interface tissue from the mixture of removed tissues for studying physiological SAR during early human pregnancy. Using stereomicroscopy, basal decidual tissues containing residual villi embedded within or surrounding groove-like depressions were meticulously separated (Figure 2A). CK7 staining of longitudinal tissue sections revealed the typical structural features of an intact maternal-fetal interface. Based on the spatial distribution of CK7-positive uterine glands, the decidua was categorized into two layers: compacta and spongiosa decidua (Figure 2B), corresponding to superficial and deep regions of embryonic implantation, respectively [27].
Figure 2.

Morphological characteristics of human decidua basalis during 5–10 weeks of gestation. (A) Gross morphology of a gestational week (GW) 9 decidua basalis imaged from the villous-facing side under 50× stereomicroscope, showing a characteristic pale depression structure where the villous tree anchors to the decidua basalis. (B) Representative immunofluorescence staining of CK7 in a GW9 decidua basalis, showing distinct compacta and spongiosa layers separated by a red dashed line based on gland distribution. (C) Representative immunofluorescence images of CK7 (green) and human leukocyte antigen G (HLA-G, red) in a GW7 decidua basalis with anchoring villi. Nuclei are counterstained with DAPI (blue). (D) Representative immunofluorescence staining of HLA-G (red) and E-cad (white) in a GW7 decidua basalis with anchoring villi. DAPI marks nuclei (blue). (E) Representative immunofluorescence image of a GW9 decidua basalis showing SAs at different stages of remodeling. HLA-G (green) labels EVTs, NCAM1 (red) marks uterine natural killer (uNK) cells, vWF (white) labels ECs, αSMA (cyan) marks smooth muscle (SM) cells, and DAPI (blue) marks nuclei. uNK cells, iEVTs, and enEVTs are marked by star, arrow, and arrowhead, respectively. AV, anchoring villus; D, decidua; E-cad, E-cadherin; V, villous-facing side; M, myometrial-facing (uterine muscle detachment) side. Scale bars: Yellow = 100 μm; White = 50 μm.
Immunofluorescence microscopy identified CK7-positive anchoring villi and CK7/HLA-G double-positive trophoblasts derived from distal CCCs within the compacta layer (Figure 2C). E-cadherin staining showed a progressive decrease in intensity from villous trophoblasts to iEVTs infiltrating the decidual stroma (Figure 2D), suggesting epithelial-mesenchymal transition during EVT differentiation, which is consistent with previous findings [32]. Multiplex immunofluorescence analyses were performed using markers for ECs (vWF), VSMCs (αSMA), EVTs (HLA-G), iEVTs (HLA-G+/NCAM1−), and enEVTs (HLA-G+/NCAM1+) to delineate spatial interactions among key fetal-derived (iEVT, enEVT) and maternal-derived (ECs, VSMCs, dNK cells) cell types at the maternal-fetal interface (Figure 2E). Blood vessels positive for vWF and/or αSMA were observed in both the compacta and spongiosa layers. HLA-G+/NCAM1+ enEVTs were detected within SAs exhibiting partial or complete disruption of EC and VSMC layers, indicating various stages of SAR. Notably, the SMC layers of actively remodeling SAs were frequently infiltrated by NCAM1+ dNK cells. These remodeling vessels showed significantly higher dNK cell clustering density during early gestation, suggesting a potential role for dNKs in the early phases of SAR.
Spatiotemporal dynamics of spiral artery remodeling
Successful classification of intact maternal-fetal interface samples enables accurate analysis of spatiotemporal changes in SAR during early human development. We optimized a multiplexed immunofluorescence microscopy approach to analyze longitudinal sections of the maternal-fetal interface from 5 to 10 weeks of gestation. Consistent with our previous findings [31], un-remodeled SAs appeared small, characterized by an intact vWF-positive EC lining and multilayered αSMA-positive VSMCs. These vessels were surrounded with or without NCAM1−/HLA-G+ iEVTs, but critically, all lacked luminal NCAM1+/HLA-G+ enEVTs. In contrast, actively remodeling SAs showed enlarged lumens and were surrounded by NCAM1−/HLA-G+ iEVTs. The EC/VSMC layers were partially diminished and progressively replaced by NCAM1+/HLA-G+ enEVTs within the lumen. Fully remodeled SAs displayed the largest lumens, complete replacement of ECs by NCAM1+/HLA-G+ enEVTs, which were also surrounded by NCAM1−/HLA-G+ iEVTs (Figure 3A).
Figure 3.
Dynamic SAR in human decidua basalis during 5–10 weeks of gestation. (A) Representative multiplex immunofluorescence images showing SAs in the compacta and spongiosa layers of the decidua basalis at different gestational stages. Green: HLA-G (EVTs); Red: NCAM1 (uNK cells); White: vWF (ECs); Cyan: αSMA (smooth muscle cells); Blue: DAPI (nuclei). SAs were categorized as: Un-remodeled (Un-Rem): intact αSMA-positive smooth muscle (SM) and vWF-positive EC layers (left panel); actively remodeling (Act-Rem): partially disrupted SM layer with infiltration of HLA-G+ EVTs and NCAM1+ uNK cells (middle panel); and fully remodeled (Fully-Rem): complete loss of SMC/EC layers replaced by HLA-G+ EVTs and NCAM1+ uNK cells (right panel). Scale bar: 50 μm. (B) Schematic of sectioning strategy. Approximately 200 serial paraffin sections were collected per case; every 20th section was used for quantitative analysis of SAR. (C) Bar graph showing the percentage of un-remodeled, actively remodeling, and fully remodeled SAs in compacta and spongiosa layers, stratified by gestational age. Detailed statistics are provided in Table 2. (D) Bar graph summarizing luminal areas of SAs in different remodeling stages (Un-Rem, Act-Rem, Fully-Rem) at each gestational age. Each symbol represents an individual case (n = 3 per group). All SAs within each analyzed section were counted. Pairwise comparisons were made with t-tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001
We grouped 15 maternal-fetal interface specimens into three gestational age categories: 5–6 weeks, 7–8 weeks, and 9–10 weeks (n = 3 per group; Table 2). Spiral artery remodeling dynamics were quantified based on gestational age and trophoblast invasion depth (decidua compacta vs. spongiosa) using 10 sections from every 20th slice from a total of 200 sections continuously cut from each case (Figure 3B). The extent of SAR increased significantly from 5–6 to 9–10 weeks of gestation. Specifically, the proportion of un-remodeled SAs decreased from approximately 40% at 5–6 weeks to 14% at 9–10 weeks, while fully remodeled SAs increased from 5% to 20% during the same interval (Figure 3C, Table 2). At 5–6 weeks, the spongiosa region exhibited a higher proportion of un-remodeled SAs compared to the compacta. However, by 7–8 and 9–10 weeks, SAR progression became comparable between these regions (Figure 3C, Table 2). Lumen area measurements revealed a significant increase across gestation. The mean lumen areas of actively remodeling and fully remodeled SAs were: 4840.79 ± 3936.71 μm2 at 5–6 weeks, 7709.08 ± 6179.37 μm2 at 7–8 weeks, and 19 586.78 ± 13 991.63 μm2 at 9–10 weeks (Figure 3D), with statistically significant differences among the groups (P < 0.001).
Table 2.
Spatiotemporal SAR in early human development.
| Group | 5–6 weeks case No.# (GA) | 7–8 weeks case No.# (GA) | 9–10 weeks case No.# (GA) | ||||
|---|---|---|---|---|---|---|---|
| Un-Rem | Compacta [n (%)] | 1#(5w) | 31 (38.75) | 6#(7w) | 6 (20.00) | 11#(9w) | 12 (15.00) |
| 2#(6w) | 23 (43.40) | 7#(7w) | 6 (20.69) | 12#(9w) | 7 (17.07) | ||
| 4#(6w) | 23 (32.86) | 9#(8w) | 16 (29.09) | 15#(10w) | 7 (9.46) | ||
| M ± SD (%) | 38.34 ± 5.28 | 23.26 ± 5.06a | 13.84 ± 3.93b | ||||
| Spongiosa [n (%)] | 1#(5w) | 7 (38.89) | 6#(7w) | 12 (16.90) | 11#(9w) | 5 (20.83) | |
| 2#(6w) | 18 (47.37) | 7#(7w) | 8 (26.67) | 12#(9w) | 4 (12.90) | ||
| 4#(6w) | 26 (37.68) | 9#(8w) | 13 (24.07) | 15#(10w) | 6 (8.82) | ||
| M ± SD (%) | 41.31 ± 5.28 | 22.55 ± 5.06a | 14.18 ± 6.11b | ||||
| Act-Rem | Compacta [n (%)] | 1#(5w) | 45 (56.25) | 6#(7w) | 21 (70.00) | 11#(9w) | 49 (61.25) |
| 2#(6w) | 26 (49.06) | 7#(7w) | 18 (62.07) | 12#(9w) | 27 (65.85) | ||
| 4#(6w) | 45 (64.29) | 9#(8w) | 27 (49.09) | 15#(10w) | 49 (66.22) | ||
| M ± SD (%) | 56.53 ± 7.62 | 60.39 ± 10.56 | 64.44 ± 2.77 | ||||
| Spongiosa [n (%)] | 1#(5w) | 11 (61.11) | 6#(7w) | 55 (77.46) | 11#(9w) | 15 (62.50) | |
| 2#(6w) | 20 (52.63) | 7#(7w) | 19 (63.33) | 12#(9w) | 20 (64.52) | ||
| 4#(6w) | 43 (62.32) | 9#(8w) | 33 (61.11) | 15#(10w) | 47 (69.12) | ||
| M ± SD (%) | 58.69 ± 5.28 | 67.30 ± 8.87 | 65.38 ± 3.39 | ||||
| Fully-Rem | Compacta [n (%)] | 1#(5w) | 4 (5.00) | 6#(7w) | 3 (10.00) | 11#(9w) | 19 (23.75) |
| 2#(6w) | 4 (7.55) | 7#(7w) | 5 (17.24) | 12#(9w) | 7 (17.07) | ||
| 4#(6w) | 2 (2.86) | 9#(8w) | 12 (21.82) | 15#(10w) | 18 (24.32) | ||
| M ± SD (%) | 5.14 ± 2.35 | 16.35 ± 5.96a | 21.71 ± 4.03b | ||||
| Spongiosa [n (%)] | 1#(5w); | 0 (0) | 6#(7w) | 4 (5.63) | 11#(9w) | 4 (16.67) | |
| 2#(6w) | 0 (0) | 7#(7w) | 3 (10.00) | 12#(9w) | 7 (22.58) | ||
| 4#(6w) | 0 (0) | 9#(8w) | 8 (14.81) | 15#(10w) | 15 (22.06) | ||
| M ± SD (%) | 0L | 10.15 ± 4.59a | 20.44 ± 3.27b,c | ||||
GA, gestational age; M, mean; SD, standard deviation; Un-Rem, Un-remodeled; Act-Rem, actively remodeling; Fully-Rem, fully remodeled.
Statistical analysis of gestation week groups was performed by t-test, and P < 0.05 was considered statistically significant. Pairwise comparisons were denoted with superscripts “a, b, c,” representing comparisons between 5–6 weeks vs. 7–8 weeks, 5–6 weeks vs. 9–10 weeks, and 7–8 weeks vs. 9–10 weeks, respectively. Statistical analysis comparing decidual compacta and spongiosa was performed by t-test. P < 0.05 was deemed statistically significant and denoted with the superscript “L”.
Spatiotemporal dynamics of extravillous trophoblast plugs
The formation of intraluminal HLA-G+/NCAM1+ enEVT plugs is a pivotal event in SAR [14]. We further classified enEVT plugs into two subtypes based on their morphology and extent of lumen occupancy: 1) tight plugs composed of densely aggregated enEVTs occupying more than two-thirds of the vessel lumen, and 2) loose plugs consisting of loosely associated enEVTs occupying less than two-thirds of the lumen (Figure 4A and B). Using multiplex immunofluorescence imaging, we quantified these enEVT plug subtypes across gestational age groups (5–6, 7–8, and 9–10 weeks; n = 3 per group) and by decidual zone (compacta vs. spongiosa), analyzing every 20th section from a total of 200 serial slices per specimen. As summed up in Table 3, enEVT plugs were exclusively detected in the compacta region at 5–6 weeks of gestation. From 7–10 weeks, plugs were observed in both compacta and spongiosa regions. Across all timepoints, the prevalence of SAs containing enEVT plugs was significantly higher in the compacta compared to the spongiosa, and this prevalence increased progressively with gestational age. Furthermore, tight plugs formed more frequently in the compacta decidua, while loose plugs were more commonly observed in the spongiosa (Figure 4C, Table 3). These findings highlight a spatial and temporal regulation of enEVT plug formation during early pregnancy and support a compartment-specific role for trophoblast invasion in SAR progression.
Figure 4.
Dynamic changes in enEVT plugs at the maternal-fetal interface during 5–10 weeks of gestation. (A–B) Representative multiplex immunofluorescence images of SAs in the decidua basalis showing different subtypes of enEVT plugs within the arterial lumen: (B) Tight plug in a GW7 specimen, characterized by densely packed enEVTs occupying >2/3 of the lumen. (C) Loose plug in a GW8 specimen, composed of loosely aggregated enEVTs occupying <2/3 of the lumen. Green: HLA-G (EVTs); Red: NCAM1 (dNK cells); White: vWF (ECs); Cyan: αSMA (smooth muscle cells); Blue: DAPI (nuclei). Yellow arrows indicate enEVT plugs. Scale bar: 50 μm. (C) Bar graphs summarizing the mean prevalence of tight and loose enEVT plugs in the compacta and spongiosa layers of the decidua basalis across gestational ages. All SAs in each stained section were analyzed. Approximately 200 serial sections were prepared per case, and every 20th section was stained and quantified. Detailed statistics for enEVT plug prevalence by gestational week are provided in Table 3.
Table 3.
Spatiotemporal enEVT plug formation in early human development.
| Group | 5–6 weeks case No.# (GA) | 7–8 weeks case No.# (GA) | 9–10 weeks case No.# (GA) | ||||
|---|---|---|---|---|---|---|---|
| Without Plug | Compacta [n (%)] | 1#(5w) | 26 (92.85) | 6#(7w) | 13 (81.25) | 11#(9w) | 13 (65.00) |
| 3#(6w) | 27 (81.82) | 8#(7w) | 18 (66.67) | 12#(9w) | 20 (64.52) | ||
| 5#(6w) | 20 (83.33) | 10#(8w) | 14 (77.78) | 15#(10w) | 23 (67.65) | ||
| M ± SD (%) | 86.00 ± 5.98 | 75.23 ± 7.62 | 65.72 ± 1.69b | ||||
| Spongiosa [n (%)] | 1#(5w) | 15 (100.00) | 6#(7w) | 21 (91.30) | 11#(9w) | 28 (80.00) | |
| 3#(6w) | 9 (100.00) | 8#(7w) | 17 (80.95) | 12#(9w) | 18 (90.00) | ||
| 5#(6w) | 11 (100.00) | 10#(8w) | 12 (92.31) | 15#(10w) | 26 (89.66) | ||
| M ± SD (%) | 100.00 ± 0L | 88.19 ± 6.29a | 86.55 ± 5.68b,L | ||||
| Loose Plug | Compacta [n (%)] | 1#(5w) | 0 (0) | 6#(7w) | 0 (0) | 11#(9w) | 2 (10.00) |
| 3#(6w) | 2 (6.06) | 8#(7w) | 4 (14.81) | 12#(9w) | 4 (12.90) | ||
| 5#(6w) | 1 (4.17) | 10#(8w) | 1 (5.56) | 15#(10w) | 4 (11.76) | ||
| M ± SD (%) | 3.41 ± 3.10 | 6.79 ± 7.48a | 11.55 ± 1.46b | ||||
| Spongiosa [n (%)] | 1#(5w) | 0 (0) | 6#(7w) | 2 (8.70) | 11#(9w) | 5 (14.29) | |
| 3#(6w) | 0 (0) | 8#(7w) | 3 (14.29) | 12#(9w) | 2 (10.00) | ||
| 5#(6w) | 0 (0) | 10#(8w) | 1 (7.69) | 15#(10w) | 2 (6.90) | ||
| M ± SD (%) | 0 | 10.23 ± 3.56a | 10.40 ± 3.71b | ||||
| Tight Plug | Compacta [n (%)] | 1#(5w) | 2 (7.14) | 6#(7w) | 3 (18.75) | 11#(9w) | 5 (25.00) |
| 3#(6w) | 4 (12.12) | 8#(7w) | 5 (18.52) | 12#(9w) | 7 (22.58) | ||
| 5#(6w) | 3 (12.50) | 10#(8w) | 3 (16.67) | 15#(10w) | 7 (20.59) | ||
| M ± SD (%) | 10.59 ± 2.99 | 17.98 ± 1.14a | 22.72 ± 2.21b,c | ||||
| Spongiosa [n (%)] | 1#(5w) | 0 (0) | 6#(7w) | 0 (0) | 11#(9w) | 2 (5.71) | |
| 3#(6w) | 0 (0) | 8#(7w) | 1 (4.76) | 12#(9w) | 0 (0) | ||
| 5#(6w) | 0 (0) | 10#(8w) | 0 (0) | 15#(10w) | 1 (3.45) | ||
| M ± SD (%) | 0L | 1.59 ± 2.75L | 3.05 ± 2.88L | ||||
GA, gestational age; M, mean; SD, standard deviation.
Statistical analysis of gestation week groups was performed by t-test, and P < 0.05 was considered statistically significant. Pairwise comparisons were denoted with superscripts “a, b, c,” representing comparisons between 5–6 weeks vs. 7–8 weeks, 5–6 weeks vs. 9–10 weeks, and 7–8 weeks vs. 9–10 weeks, respectively. Statistical analysis comparing decidual compacta and spongiosa was performed by t-test. P < 0.05 was deemed statistically significant and denoted with the superscript “L”.
Discussion
Spiral artery remodeling is a critical event in hemochorial placentation and is conserved across rodents, nonhuman primates, and humans. The similarities in placental development among these species have facilitated the use of animal models to gain valuable insights into human SAR [33, 34]. However, significant interspecies differences in trophoblast differentiation and invasion, cell compositions, and cell–cell interactions at the maternal-fetal interface limit the direct applicability of these animal models to understanding physiological SAR in humans. To comprehensively elucidate physiological SAR during human placentation and investigate abnormal SAR linked to pregnancy complications such as miscarriages, fetal growth restriction, and the uniquely human pregnancy disorder preeclampsia, fresh human maternal-fetal interface specimens are indispensable [13, 35]. Currently, specimens obtained from elective abortion procedures between 5 and 10 weeks of gestation represent the primary source for cellular and molecular mechanistic studies of human placentation. However, obtaining high-quality specimens with an intact maternal-fetal interface remains challenging due to tissue fragmentation and dispersion caused by the surgical procedure. Variability in collection and processing protocols contributes to substantial differences in sample quality, which likely underlies the inconsistent or even contradictory observations of SAR dynamics reported across different studies [3, 11, 13, 14, 16–19, 22, 27, 31].
Endometrial stromal cells differentiate into specialized decidualized cells approximately 5–8 days post-fertilization. Decidualization initiates at the site of embryo implantation and subsequently forms the functional decidua basalis which contains the maternal-fetal interface. This process then extends throughout the uterine endometrium, resulting in the formation of the decidua capsularis and decidua parietalis. Our morphological and immunohistochemical analyses of aborted tissue specimens confirmed the presence of three distinct decidual tissue types corresponding to the capsular, parietal, and basal decidua. These detailed structural characterizations enabled us to develop a standardized protocol for isolating basal decidua specimens that retain an intact maternal-fetal interface from the heterogeneous mixture of aborted tissues. Moreover, we demonstrate that these isolated decidua basalis tissues are well-suited for quantifying the spatiotemporal dynamics of SAR. Utilizing multiplexed immunofluorescence microscopy with specific markers for the major cell types at the maternal-fetal interface, including EVTs, dNK cells, ECs, and VSMCs, our analyses have established a robust and reproducible method to quantify physiological SAR dynamics from 5 to 10 weeks of gestation using fresh human maternal-fetal interface specimens derived from aborted materials (Graphical Abstract).
Notably, we observed that SAR initiates in SAs located within the decidua compacta as early as week 5 of gestation, characterized by infiltration of NCAM1+ dNK cells and migration of NCAM1−/HLA-G+ iEVTs into the SA’s medial layer (Figure 3A). Luminal NCAM1+/HLA-G+ enEVTs first appear in actively remodeling SAs during weeks 5–6, coinciding with the formation of tight enEVT plugs. As gestation progresses, these tight plugs transition into loose plugs, with a progressive replacement of EC layer by enEVTs. These observations align with prior studies that describe SAR as primarily an intravascular process [8]. Furthermore, NCAM1+ dNK cells and NCAM1−/HLA-G+ iEVTs initially localize to the interstitial space surrounding un-remodeled SAs and subsequently spread to actively and fully remodeled SAs as gestation advances (Figure 3). Given that dNK cells can directly disrupt the arterial muscular lining and indirectly facilitate iEVT invasion into SAs [36], our data support the notion in which SAR begins outside the vessels with recruitment of dNK cells. Additionally, approximately 56% of SAs undergo active remodeling in both the compacta and spongiosa decidua during weeks 5–6 (Figure 3A and B), temporally coinciding with CTB differentiation into EVTs around day 21 post-fertilization [37]. Our findings on SAR progression in compacta versus spongiosa decidua across weeks 5–6, 7–8, and 9–10 (Figure 3C and D) are consistent with previous reports describing SAR initiation at the implantation site (compacta decidua) followed by distal progression toward the spongiosa decidua [14]. However, we also found that the lumen areas of un-remodeled SAs gradually increase from weeks 5 to 10, suggesting a novel enEVT-independent pathway for remodeling. This may involve dedifferentiation of VSMCs through interactions with decidual stromal and immune cells [31].
We also observed that tight enEVT plugs form in fewer than 10% of SAs at week 5 of gestation, while loose enEVT plugs begin to appear gradually after week 7. Subsequently, the proportion of SAs containing loose plugs progressively increases in the decidua compacta as gestation advances (Figure 4, Table 3). These findings indicate a critical role of the formation of enEVT plugs and their temporal transition from tight to loose plug morphology in SAR. Specifically, tight plugs formed during weeks 5–6 obstruct blood flow, creating a hypoxic microenvironment that promotes angiogenesis and vessel expansion at this early stage [19, 22]. The loosening of these plugs, coinciding with a significantly higher proportion of fully remodeled SAs at weeks 9–10, signifies the completion of SAR and the establishment of blood flow into the intervillous space. Despite these insights, the mechanisms regulating the formation and dissolution of enEVT plugs throughout SAR, as well as the process by which enEVTs replace ECs remain to be elucidated. Notably, vessel lumen areas are smallest in un-remodeled SAs, increase during active remodeling and reach their largest size in fully remodeled vessels. This underscores that enEVT-mediated intraluminal remodeling not only enlarges vessel diameter but also reconstructs the vessel wall architecture.
While our current data are consistent with previous studies showing that enEVTs replace ECs in fully remodeled SAs [8], the molecular characteristics of enEVT plugs remain poorly understood. Our analysis reveals that enEVT plugs consist of heterogeneous cell populations, exhibiting diverse expression patterns of HLA-G and NCAM1 [21]. This heterogeneity aligns with our recent findings that enEVTs possess immune regulatory functions, including secretion of transforming growth factor-β [20]. The expression of NCAM1 suggests that enEVTs may acquire NK cell-like properties [26], potentially equipping them with the functional capacity to mediate intraluminal vascular remodeling. This hypothesis is further supported by emerging spatial multi-omics studies highlighting the functional plasticity of enEVTs [15, 28]. Moreover, the acquisition of immune regulatory properties may enable enEVTs to contribute to the establishment of immune tolerance at the maternal-fetal interface. However, the precise timing and mechanisms by which enEVTs acquire these immune functions remain to be elucidated.
Multiplex immunofluorescence microscopy enables simultaneous visualization of multiple maternal and fetal cell populations within serial sections from the same specimen, as well as across samples from different gestational ages. This approach yields novel insights into the cellular composition and spatiotemporal cell–cell interactions that drive SAR. While recent studies using single-cell and spatial transcriptomics have significantly advanced our understanding of the cellular landscape at the human maternal-fetal interface [23], these analyses are typically based on archived samples, which often lack precise gestational age resolution. In contrast, applying such high-dimensional analyses to fresh specimens collected using our standardized protocol could provide more continuous and developmentally informative data. This would allow for a finer-resolution mapping of the dynamic cellular and molecular changes occurring throughout early gestation.
It is estimated that up to 200 SAs open into the intervillous space to supply maternal blood during human pregnancy [38], although this number can vary substantially depending on gestational age [39]. In this study, we were able to quantify mean vessel lumen areas; however, we were unable to determine the total number of SAs contributing to the intervillous circulation during weeks 5–10 of gestation. This limitation arises from the nature of elective abortion procedures, which often disrupt the structural integrity of the maternal-fetal interface. As a result, it is challenging to obtain intact tissue specimens suitable for imaging for accurately counting the total number of SAs connected to the intervillous space.
In this study, we analyzed samples from a total of 15 patients and grouped the analyzed cases biweekly into three groups, i.e., 5–6, 7–8, and 9–10 weeks of gestation, for statistical analysis of SAR according to gestational age and depth of decidua (compacta vs. spongiosa). While the relatively small sample size (n = 3/group) may limit the generalizability of our findings, the analytical depth of our approach strengthens the reliability of our findings. Specifically, we analyzed at least 10 sections from every 20th slice across 200 serial sections per sample. This comprehensive sampling strategy enables accurate assessment of spatial changes in SAR and supports robust quantitative analysis of SAR progression during early gestation, although increasing sample size per gestation age will help solidify our current fundings.
Impaired or aberrant SAR is implicated in the pathogenesis of nearly all major human pregnancy complications [12], highlighting the need to investigate the mechanisms underlying physiological SAR. In this study, we analyzed samples obtained from pregnancies without known complications, thereby providing insight into normal SAR processes. Using these well-characterized samples, we previously recovered a novel fate of VSMCs during SAR; specifically, approximately 5% of VSMCs undergo dedifferentiation and transform into dNK cells [31]. Importantly, the same protocol has also been successfully applied to identify pathological maternal-fetal interface specimens from patients with recurrent miscarriages; these analyses revealed impaired immunoregulatory functions of enEVTs and insufficient SAR in patients with recurrent miscarriages [20, 21]. These findings demonstrate the utility of our protocol not only for studying physiological SAR but also for investigating pathological SAR associated with abnormal placentation and defective uteroplacental vascular remodeling. Thus, this approach can be extended to study SAR in pregnancy complications such as preeclampsia and intrauterine growth restriction, with potential applications in biomarker discovery and therapeutic target identification.
Altogether, our study establishes a standardized and reproducible protocol for classifying and isolating maternal-fetal interface tissues from heterogeneous aborted materials, enabling mechanistic investigations into early human development. Through multiplex immunofluorescence imaging with cell type-specific markers, we demonstrate that basal decidua tissues collected from gestational weeks 5 to 10 are of high quality and well-suited for comprehensive analyses of SAR. These specimens offer valuable insights into the morphological, structural, cellular, and molecular dynamics of physiological SAR during early human placentation, promoting the adoption of our methodology in future studies of abnormal SAR and related pregnancy disorders. Given the inherent variability among Homo sapiens individuals, future studies using large sample size to ensure stratified analysis with consideration of the many baseline variables such as maternal age, body mass index, gravidity, dietary, smoking, ethnicity/nationality, as well as the analysis of clinical samples from pregnancy cohorts with various pregnancy disorders, are warranted to achieve better understanding of human uterine vessel remodeling during pregnancy.
Acknowledgment
The authors thank all patients for participating in this study. We appreciate Ms. Shiwen Li, Xili Zhu, and Yue Wang at the Institute of Zoology of the Chinese Academy of Sciences for technical support in Confocal microscopy.
Contributor Information
Shenglong Ye, Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China; State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Yeling Ma, School of Medicine, Shaoxing University, Zhejiang 312000, China.
Wenlong Li, State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Linjing Qi, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Xiao Fang, State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 101408, China.
Xin Yu, State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute of Stem Cell and Regenerative Medicine, Beijing 100101, China.
Duo Yu, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Xiaoye Wang, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Dong-bao Chen, Department of Obstetrics and Gynecology, University of California Irvine, Irvine, CA 92697, USA.
Yan-Ling Wang, State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 101408, China; Beijing Institute of Stem Cell and Regenerative Medicine, Beijing 100101, China.
Conflict of interest: All authors declare no financial interests regarding this work. D.B.C. is a current associate editor of Biology of Reproduction, but with no access to the handling and peer review of this study.
Author contributions
Ye S, Chen DB, and Wang YL designed the study; Qi L, Yu D, and Wang X identified and consent patients; Ye S, Ma Y, Li W, and Qi L processed samples, carried out experiments, and collected data; Fang X and Yu X collected data; Ye SL, Chen DB, Wang YL analyzed data; Ye SL drafted the paper which was finalized by Chen DB and Wang YL.
Data availability
Original data presented in the study are included in the article and Supplementary Data. Further inquiries about the study and samples can be directed at the corresponding authors.
References
- 1. Hemberger M, Hanna CW, Dean W. Mechanisms of early placental development in mouse and humans. Nat Rev Genet 2020; 21:27–43. 10.1038/s41576-019-0169-4. [DOI] [PubMed] [Google Scholar]
- 2. Boss AL, Chamley LW, James JL. Placental formation in early pregnancy: how is the Centre of the placenta made? Hum Reprod Update 2018; 24:750–760. 10.1093/humupd/dmy030. [DOI] [PubMed] [Google Scholar]
- 3. Hamilton WJ, Boyd JD. Development of the human placenta in the first three months of gestation. J Anat 1960; 94:297–328. [PMC free article] [PubMed] [Google Scholar]
- 4. James JL, Carter AM, Chamley LW. Human placentation from nidation to 5 weeks of gestation. Part I: what do we know about formative placental development following implantation? Placenta 2012; 33:327–334. 10.1016/j.placenta.2012.01.020. [DOI] [PubMed] [Google Scholar]
- 5. James JL, Carter AM, Chamley LW. Human placentation from nidation to 5 weeks of gestation. Part II: tools to model the crucial first days. Placenta 2012; 33:335–342. 10.1016/j.placenta.2012.01.019. [DOI] [PubMed] [Google Scholar]
- 6. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1:3–19. [DOI] [PubMed] [Google Scholar]
- 7. Degner K, Magness RR, Shah DM. Establishment of the human uteroplacental circulation: a historical perspective. Reprod Sci 2017; 24:753–761. 10.1177/1933719116669056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99:2139–2151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30:473–482. 10.1016/j.placenta.2009.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Conrad KP, Rabaglino MB, Post Uiterweer ED. Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta 2017; 60:119–129. 10.1016/j.placenta.2017.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Burton GJ, Jauniaux E, Watson AL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol 1999; 181:718–724. [DOI] [PubMed] [Google Scholar]
- 12. Ilekis JV, Tsilou E, Fisher S, Abrahams VM, Soares MJ, Cross JC, Zamudio S, Illsley NP, Myatt L, Colvis C, Costantine MM, Haas DM, et al. Placental origins of adverse pregnancy outcomes: potential molecular targets: an executive workshop summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol 2016; 215:S1–S46. 10.1016/j.ajog.2016.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Hamilton WJ, Boyd JD. Trophoblast in human utero-placental arteries. Nature 1966; 212:906–908. [DOI] [PubMed] [Google Scholar]
- 14. Roberts VHJ, Morgan TK, Bednarek P, Morita M, Burton GJ, Lo JO, Frias AE. Early first trimester uteroplacental flow and the progressive disintegration of spiral artery plugs: new insights from contrast-enhanced ultrasound and tissue histopathology. Hum Reprod 2017; 32:2382–2393. 10.1093/humrep/dex301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Greenbaum S, Averbukh I, Soon E, Rizzuto G, Baranski A, Greenwald NF, Kagel A, Bosse M, Jaswa EG, Khair Z, Kwok S, Warshawsky S, et al. A spatially resolved timeline of the human maternal-fetal interface. Nature 2023; 619:595–605. 10.1038/s41586-023-06298-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hempstock J, Bao YP, Bar-Issac M, Segaren N, Watson AL, Charnock-Jones DS, Jauniaux E, Burton GJ. Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial bloodflow within the human placenta. Placenta 2003; 24:517–523. [DOI] [PubMed] [Google Scholar]
- 17. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003; 162:115–125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Huppertz B, Gauster M, Orendi K, König J, Moser G. Oxygen as modulator of trophoblast invasion. J Anat 2009; 215:14–20. 10.1111/j.1469-7580.2008.01036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Weiss G, Sundl M, Glasner A, Huppertz B, Moser G. The trophoblast plug during early pregnancy: a deeper insight. Histochem Cell Biol 2016; 146:749–756. 10.1007/s00418-016-1474-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Ma Y, Yang Q, Fan M, Zhang L, Gu Y, Jia W, Li Z, Wang F, Li YX, Wang J, Li R, Shao X, et al. Placental endovascular extravillous trophoblasts (enEVTs) educate maternal T-cell differentiation along the maternal-placental circulation. Cell Prolif 2020; 53:e12802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Ma Y, Yu X, Ye S, Li W, Yang Q, Li YX, Wang Y, Wang YL. Immune-regulatory properties of endovascular extravillous trophoblast cells in human placenta. Placenta 2024; 145:107–116. 10.1016/j.placenta.2023.12.009. [DOI] [PubMed] [Google Scholar]
- 22. Allerkamp HH, Clark AR, Lee TC, Morgan TK, Burton GJ, James JL. Something old, something new: digital quantification of uterine vascular remodelling and trophoblast plugging in historical collections provides new insight into adaptation of the utero-placental circulation. Hum Reprod 2021; 36:571–586. 10.1093/humrep/deaa303. [DOI] [PubMed] [Google Scholar]
- 23. Arutyunyan A, Roberts K, Troule K, Wong FCK, Sheridan MA, Kats I, Garcia-Alonso L, Velten B, Hoo R, Ruiz-Morales ER, Sancho-Serra C, Shilts J, et al. Spatial multiomics map of trophoblast development in early pregnancy. Nature 2023; 616:143–151. 10.1038/s41586-023-05869-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ji L, Brkic J, Liu M, Fu G, Peng C, Wang YL. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol Asp Med 2013; 34:981–1023. 10.1016/j.mam.2012.12.008. [DOI] [PubMed] [Google Scholar]
- 25. Loke YW, King A, Burrows T, Gardner L, Bowen M, Hiby S, Howlett S, Holmes N, Jacobs D. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens 1997; 50:135–146. [DOI] [PubMed] [Google Scholar]
- 26. Martinez AL, Shannon MJ, Sloan T, Mace EM. CD56/NCAM mediates cell migration of human NK cells by promoting integrin-mediated adhesion turnover. Mol Biol Cell 2024; 35:ar64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Damsky CH, Fisher SJ. Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr Opin Cell Biol 1998; 10:660–666. [DOI] [PubMed] [Google Scholar]
- 28. Vento-Tormo R, Efremova M, Botting RA, Turco MY, Vento-Tormo M, Meyer KB, Park JE, Stephenson E, Polanski K, Goncalves A, Gardner L, Holmqvist S, et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature 2018; 563:347–353. 10.1038/s41586-018-0698-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 1979; 279:636–638. [DOI] [PubMed] [Google Scholar]
- 30. Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012; 95:156–164. 10.1093/cvr/cvs115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Ma Y, Yu X, Zhang L, Liu J, Shao X, Li Y-x, Wang Y-L. Uterine decidual niche modulates the progressive dedifferentiation of spiral artery vascular smooth muscle cells during human pregnancy†. Biol Reprod 2021; 104:624–637. 10.1093/biolre/ioaa208. [DOI] [PubMed] [Google Scholar]
- 32. Kaufmann P, Stark J. Proceedings: normal anatomy and histology of placenta. Arch Gynakol 1973; 214:55–56. [DOI] [PubMed] [Google Scholar]
- 33. Carter AM, Enders AC. Comparative aspects of trophoblast development and placentation. Reprod Biol Endocrinol 2004; 2:46. 10.1186/1477-7827-2-46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Soncin F, Natale D, Parast MM. Signaling pathways in mouse and human trophoblast differentiation: a comparative review. Cell Mol Life Sci 2015; 72:1291–1302. 10.1007/s00018-014-1794-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Cartwright JE, Fraser R, Leslie K, Wallace AE, James JL. Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction 2010; 140:803–813. 10.1530/REP-10-0294. [DOI] [PubMed] [Google Scholar]
- 36. Sato Y. Endovascular trophoblast and spiral artery remodeling. Mol Cell Endocrinol 2020; 503:110699. 10.1016/j.mce.2019.110699. [DOI] [PubMed] [Google Scholar]
- 37. Turco MY, Moffett A. Development of the human placenta. Development 2019; 146:dev163428. 10.1242/dev.163428. [DOI] [PubMed] [Google Scholar]
- 38. Osol G, Moore LG. Maternal uterine vascular remodeling during pregnancy. Microcirculation 2014; 21:38–47. 10.1111/micc.12080. [DOI] [PubMed] [Google Scholar]
- 39. Harris JWS, Ramsey EM. The Morphology of Human Uteroplacenta Vasculature. DC, USA: Carnegie Institution of Washington; 1966: 43–58. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Original data presented in the study are included in the article and Supplementary Data. Further inquiries about the study and samples can be directed at the corresponding authors.



